Stockscreener 앱 받기
0.6277
3.56%
0.0216
시간 외 거래:
.68
0.0523
+8.33%
전일 마감가:
$0.6061
열려 있는:
$0.61
하루 거래량:
555.70K
Relative Volume:
1.60
시가총액:
$91.63M
수익:
$49.09M
순이익/손실:
$-52.15M
주가수익비율:
-0.9657
EPS:
-0.65
순현금흐름:
$-45.93M
1주 성능:
-16.53%
1개월 성능:
-20.84%
6개월 성능:
-64.13%
1년 성능:
-57.87%
1일 변동 폭
$0.61
$0.68
1주일 범위
$0.5921
$0.7754
52주 변동 폭
$0.5921
$2.04
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
BDSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
0.6277 | 91.63M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
489.06 | 182.21B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.16 | 143.37B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
426.25 | 33.92B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
115.99 | 33.08B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
174.37 | 30.19B | 15.41B | 1.37B | 2.11B | 7.50 |
바이오데식스 Stock (BDSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-07-26 | 개시 | Craig Hallum | Buy |
| 2024-05-13 | 개시 | TD Cowen | Buy |
| 2024-05-03 | 개시 | Lake Street | Buy |
| 2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 개시 | BTIG Research | Buy |
| 2020-11-23 | 개시 | Canaccord Genuity | Buy |
| 2020-11-23 | 개시 | Morgan Stanley | Overweight |
| 2020-11-23 | 개시 | William Blair | Outperform |
모두보기
바이오데식스 주식(BDSX)의 최신 뉴스
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 29.5% in March - MarketBeat
AIGH Capital Management LLC Has $9.46 Million Holdings in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
Perkins Capital Management Inc. Purchases 335,429 Shares of Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Update - MarketBeat
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier - Business Wire
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 24.6% in February - Defense World
Biodesix to Present at Cowen’s 42nd Annual Healthcare Conference - Business Wire
Biodesix chief commercial officer sells shares worth $16,198 - MSN
Q1 Earnings Estimate for Biodesix Issued By William Blair - MarketBeat
Biodesix's (BDSX) "Outperform" Rating Reaffirmed at William Blair - MarketBeat
Biodesix (NASDAQ:BDSX) Issues Quarterly Earnings Results - MarketBeat
Q1 Earnings Forecast for Biodesix Issued By William Blair - Defense World
Biodesix (BDSX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Biodesix improved sales, cut losses in fourth quarter, fiscal 2024 - BizWest
Biodesix at TD Cowen Conference: Transformative Year Ahead By Investing.com - Investing.com UK
Biodesix at TD Cowen Conference: Transformative Year Ahead - Investing.com
Analysts Have Been Trimming Their Biodesix, Inc. (NASDAQ:BDSX) Price Target After Its Latest Report - Yahoo Finance
William Blair Estimates Biodesix’s Q1 Earnings (NASDAQ:BDSX) - Defense World
It's Down 30% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks - Simply Wall St
Biodesix (NASDAQ:BDSX) Receives “Outperform” Rating from William Blair - Defense World
Biodesix, Inc. Reports Strong Growth Amid Financial Challenges - TipRanks
Positive Outlook for Biodesix: Buy Rating Supported by Salesforce Improvements and Revenue Growth Opportunities - TipRanks
Earnings call transcript: Biodesix Q4 2024 beats revenue expectations By Investing.com - Investing.com South Africa
Observations on the Biodesix Inc (NASDAQ:BDSX) Growth Curve - US Post News
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript - MSN
Biodesix: Strong Growth and Promising Future with Buy Rating from Kyle Mikson CFA - TipRanks
US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says ExpertCrowdStrike Holdings (NASDAQ:CRWD), Biodesix (NASDAQ:BDSX) - Benzinga
Biodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 2025 - Insider Monkey
12 Penny Stocks with Insider Buying in 2025 - Insider Monkey
BDSX Shrinks Loss With Revenue Growth, ALLR Plans $5Mln Share Buyback, What's The Buzz At PTIX? - RTTNews
Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Biodesix Reports Strong 2024 Financial Performance - TipRanks
Biodesix Inc reports results for the quarter ended December 31Earnings Summary - TradingView
BIODESIX Earnings Results: $BDSX Reports Quarterly Earnings - Nasdaq
Earnings call transcript: Biodesix Q4 2024 beats revenue expectations - Investing.com
Biodesix earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Earnings Flash (BDSX) BIODESIX INC. Reports Q4 Revenue $20.4M, vs. FactSet Est of $19.9M - Marketscreener.com
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results - GlobeNewswire
Biodesix chief accounting officer Chris Vazquez sells $3,354 in stock - MSN
Biodesix (BDSX) Expected to Announce Quarterly Earnings on Monday - Defense World
Biodesix Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead O - GuruFocus.com
Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Biodesix (BDSX) to Release Earnings on Monday - MarketBeat
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
1.81%
자본화:
|
볼륨(24시간):